COMPANY PROFILE

Muse

Explore full profile

Develops a headband that is a sensory device that helps with meditation by providing EEG based feedback

Toronto, CanadaFounded 2009Health Tech & Medtech

Valuation $50–100M Last recorded · 2022

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

At a glance

Status: Operational
Founded: 2009
Headquarters: Toronto, Canada
Employees: 59
Open positions: None listed
Dealroom signal: 66.4/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Neurology, Mental Health, Meditation, Spinout, DT and LS, science-based
Technology: Deep Tech, Mobile app, IoT InternetOfThings
Business model: Manufacturing
Client focus: b2c
Links: Website X

Founder mafia, market maps, research and news connected to this company by Dealroom

7 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES C✓Equity / VC	Aug 2022	$9.5M	$58M	Xiamen Intretech · Iter Investments · Export Development Canada · BDC Capital	↗
SERIES B✓Equity / VC	Nov 2017	$12M	$46M	OMERS Ventures · Trend Forward Capital · Trend Forward Capital · Export Development Canada	—

Muse website traffic

Latest recorded traffic for Muse is 180K monthly website visits, up 0% over the last three months. Muse's team grew 0% over the past year.

Latest monthly visits180K 3-month web change0% 1-year team growth0%

Monthly website visitsOct 2017–Jul 2026

Summary metrics are public; monthly history is available with a demoCompare with peers →

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
FNFlow NeuroscienceDevelops a new kind of depression treatment which combines an easy-to-use brain stimulation headset with a personalized mobile app	Malmö kommun, Sweden	Operational	41	$12M	$37M
GKGlobal KineticsContinuous motor symptom quantification for Parkinson's disease.	Melbourne, Australia	Acquired
NENeurosteerNeurosteer has developed a first of its kind, continuous neurological bedside monitor and wellness wearable	Herzliya, Israel	Operational
NENeuralDxDiagnostic technology for psychiatric and neurological disorders	Melbourne, Australia	Operational
EPEpitelPlatform for brain health insight backed by powerful data analytics	Salt Lake City, United States	Operational
HDHead DiagnosticsNew Medical Devices for Parkinson's Disease Diagnosis and Monitoring. Medical Device for Neuro Disease and Brain Injury	Dublin, Ireland	Operational
HCHippoScreen Neurotech Corp.Provides electroencephalogram (EEG) based solution for mental health assessment	Taiwan	Operational
RERetiSpecRetiSpec is a medical imaging company developing a tool for the early detection of Alzheimer’s disease biomarkers in the eye	Canada	Operational